Navigation Links
Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
Date:5/12/2008

d integrated FFR lesion severity assessment. Mr. Huennekens continued, "By adding high resolution rotational IVUS and pressure-based FFR to our phased array s5 imaging platform, we provide a level of technology, clinical utility and convenience that is un-matched in the intravascular imaging field. No other company provides a system that integrates this level of functionality and convenience in a single platform. Our message now is simple: Volcano offers physicians all three technologies on one system -- you can choose which technology is best for your patient and clinical team."

Earlier generation consoles included only one of the three technologies now available on the s5i. If a hospital wanted to equip a new lab with all three technologies, they would have to acquire three separate consoles, each with a different measurement modality, training requirements and data storage protocols. The Volcano s5i can now accommodate three primary intravascular diagnostic tools in regular use by cardiologists today (high frequency rotational IVUS, fast and simple phased array IVUS, and pressure-based FFR guidewires) on a single platform, making Volcano's s5 and s5i imaging systems more flexible than ever before.

Presence at EuroPCR08

Volcano's presence at the EuroPCR 2008 Congress in Barcelona will include live case transmissions with IVUS, FFR, and OCT, scientific symposia sponsorship, first-in-man clinical experience and live product demonstrations at Volcano booth #B02. Volcano will also participate in the following scientific symposia during the program.

Title Date & Time Location

"Controversies in Coronary

Intravascular Imaging" May 14th, 12:00 - 13:30 Room 3

"Optimizing stent implantation and

minimizing irradiation for complex

PCI" with GE Healthcare May 15th, 16:30 - 18:30 Room 6

"IVUS Virtual Histology for Physic
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
2. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
3. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
4. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
5. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
6. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
7. Volcano Announces Closing of CardioSpectra Acquisition
8. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
9. Volcano Corporation Announces Pricing of Common Stock Offering
10. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
11. NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect
Post Your Comments:
*Name:
*Comment:
*Email: